Company
Headquarters: Hangzhou, China
Employees: 505
CN¥8.39 Billion
CNY as of Jan. 1, 2025
US$1.15 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Zhejiang Garden Bio-chemical High-tech Co., Ltd., together with its subsidiaries, manufactures and supplies vitamin D3, cholesterol, and calcifediol in China. Its products have applications in food additives, nutrition and health products, and medicine. The company was founded in 2000 and is based in Dongyang, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥1.13 B |
| EBITDA | CN¥323.9 M |
| Gross Profit TTM | CN¥655.3 M |
| Profit Margin | 25.11% |
| Operating Margin | 37.03% |
| Quarterly Revenue Growth | 40.00% |
Zhejiang Garden Bio-chemical High-tech Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300401 wb_incandescent